Neuropathologists assess vast brain areas to identify diverse and subtly-differentiated morphologies. Standard semi-quantitative scoring approaches, however, are coarse-grained and lack precise neuroanatomic localization. We report a proof-of-concept deep learning pipeline that identifies specific neuropathologies-amyloid plaques and cerebral amyloid angiopathy-in immunohistochemically-stained archival slides. Using automated segmentation of stained objects and a cloud-based interface, we annotate > 70,000 plaque candidates from 43 whole slide images (WSIs) to train and evaluate convolutional neural networks. Networks achieve strong plaque classification on a 10-WSI hold-out set (0.993 and 0.743 areas under the receiver operating charact...
Identification of amyloid beta ( Aβ ) plaques in the cerebral cortex in models of Alzheimer’s Diseas...
Datasets containing 63 whole slide images (WSIs) and their segmented 256x256 pixel tiles with approx...
Although there is no treatment for ADs (Alzheimer's Diseases), accurate and early diagnosis is criti...
Neuropathologists assess vast brain areas to identify diverse and subtly-differentiated morphologies...
Pathologists can label pathologies differently, making it challenging to yield consistent assessment...
Abstract Traditionally, analysis of neuropathological markers in neurodegenerative diseases has reli...
Precise, scalable, and quantitative evaluation of whole slide images is crucial in neuropathology. W...
International audienceQuantifying the distribution and morphology of tau protein structures in brain...
Semi-quantitative scoring schemes like the Consortium to Establish a Registry for Alzheimer's Diseas...
Many classical machine learning techniques have been used to explore Alzheimer's disease (AD), evolv...
Heterogeneity of brain diseases is a challenge for precision diagnosis/prognosis. We describe and va...
The determination of Alzheimer’s disease (AD) from neuroimaging data such as MRI has been immensely ...
Alzheimer disease (AD) is a neurodegenerative disorder characterized pathologically by the presence ...
We develop a deep learning approach, in silico immunohistochemistry (IHC), which takes routinely col...
Identification of amyloid beta ( Aβ ) plaques in the cerebral cortex in models of Alzheimer’s Diseas...
Datasets containing 63 whole slide images (WSIs) and their segmented 256x256 pixel tiles with approx...
Although there is no treatment for ADs (Alzheimer's Diseases), accurate and early diagnosis is criti...
Neuropathologists assess vast brain areas to identify diverse and subtly-differentiated morphologies...
Pathologists can label pathologies differently, making it challenging to yield consistent assessment...
Abstract Traditionally, analysis of neuropathological markers in neurodegenerative diseases has reli...
Precise, scalable, and quantitative evaluation of whole slide images is crucial in neuropathology. W...
International audienceQuantifying the distribution and morphology of tau protein structures in brain...
Semi-quantitative scoring schemes like the Consortium to Establish a Registry for Alzheimer's Diseas...
Many classical machine learning techniques have been used to explore Alzheimer's disease (AD), evolv...
Heterogeneity of brain diseases is a challenge for precision diagnosis/prognosis. We describe and va...
The determination of Alzheimer’s disease (AD) from neuroimaging data such as MRI has been immensely ...
Alzheimer disease (AD) is a neurodegenerative disorder characterized pathologically by the presence ...
We develop a deep learning approach, in silico immunohistochemistry (IHC), which takes routinely col...
Identification of amyloid beta ( Aβ ) plaques in the cerebral cortex in models of Alzheimer’s Diseas...
Datasets containing 63 whole slide images (WSIs) and their segmented 256x256 pixel tiles with approx...
Although there is no treatment for ADs (Alzheimer's Diseases), accurate and early diagnosis is criti...